EA202092105A1 - Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбумина - Google Patents
Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбуминаInfo
- Publication number
- EA202092105A1 EA202092105A1 EA202092105A EA202092105A EA202092105A1 EA 202092105 A1 EA202092105 A1 EA 202092105A1 EA 202092105 A EA202092105 A EA 202092105A EA 202092105 A EA202092105 A EA 202092105A EA 202092105 A1 EA202092105 A1 EA 202092105A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lactalbumin
- alpha
- composition
- pharmaceutical
- precursor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Фармацевтический состав или состав пищевой добавки, содержащий альфа-лактальбумин и по меньшей мере одну короткоцепочечную жирную кислоту (SCFA) или ее предшественник или производное, для применения для лечения расстройств центральной нервной системы; указанная SCFA или ее предшественник или производное могут содержаться по крайней мере в одной первой дозированной форме совместно с носителем, приемлемым с фармацевтической или пищевой точки зрения, и альфа-лактальбумин по крайней мере в одной второй дозированной форме совместно с носителем, приемлемым с фармацевтической или пищевой точки зрения, указанные дозированные формы могут представлять собой отдельные формы, предназначенные для одновременного или раздельного введения, или указанный состав может состоять из фармацевтической композиции или композиции пищевой добавки, содержащей указанные по меньшей мере одну короткоцепочечную жирную кислоту или ее предшественник или производное и альфа-лактальбумин совместно с носителем, приемлемым с фармацевтической или пищевой точки зрения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102018000003557A IT201800003557A1 (it) | 2018-03-14 | 2018-03-14 | Preparazione farmaceutica o di integratore alimentare a base di alfa-lattoalbumina |
PCT/EP2019/056336 WO2019175274A1 (en) | 2018-03-14 | 2019-03-13 | Pharmaceutical or food supplement preparation based on alpha-lactalbumin |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092105A1 true EA202092105A1 (ru) | 2021-02-20 |
Family
ID=62455774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092105A EA202092105A1 (ru) | 2018-03-14 | 2019-03-13 | Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбумина |
Country Status (11)
Country | Link |
---|---|
US (1) | US11554162B2 (ru) |
EP (1) | EP3764992B1 (ru) |
JP (1) | JP7372269B2 (ru) |
AU (1) | AU2019233637B2 (ru) |
BR (1) | BR112020018533A2 (ru) |
CA (1) | CA3093505A1 (ru) |
CL (1) | CL2020002369A1 (ru) |
EA (1) | EA202092105A1 (ru) |
IT (1) | IT201800003557A1 (ru) |
MX (1) | MX2020009470A (ru) |
WO (1) | WO2019175274A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202100019613A1 (it) | 2021-07-23 | 2023-01-23 | Kolfarma S R L | Formulazione farmaceutica o di integratore alimentare contenente alfa-lattoalbumina e acido butirrico o un suo sale |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096870A (en) * | 1994-01-05 | 2000-08-01 | Sepragen Corporation | Sequential separation of whey |
US6884421B2 (en) * | 2002-03-27 | 2005-04-26 | Council Of Scientific And Industrial Research | Pharmaceutical composition for diabetic nephropathy |
JP2006219458A (ja) * | 2005-02-14 | 2006-08-24 | Meiji Milk Prod Co Ltd | 虚血性腸疾患抑制剤 |
JP2010519288A (ja) * | 2007-02-21 | 2010-06-03 | パワー ペイパー リミテッド | イオン導入法のためのテルビナフィン製剤 |
WO2008138348A1 (en) * | 2007-05-09 | 2008-11-20 | Nya Hamlet Pharma Ab | Preparation of complexed lactalbumin |
IT1392333B1 (it) * | 2008-12-16 | 2012-02-28 | Giofarma S R L | Preparazione farmaceutica per il trattamento di patologie depressive, contenente una proteina con elevato rapporto triptofano/lnaa |
JP5409808B2 (ja) * | 2010-07-02 | 2014-02-05 | 森永乳業株式会社 | 治療薬および治療方法 |
CN105746711A (zh) * | 2014-12-15 | 2016-07-13 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种改善睡眠的牛奶制品及其制备方法 |
CA3004737A1 (en) * | 2015-11-09 | 2017-05-18 | Mjn U.S. Holdings Llc | Nutritional compositions containing butyrate and uses thereof |
-
2018
- 2018-03-14 IT IT102018000003557A patent/IT201800003557A1/it unknown
-
2019
- 2019-03-13 BR BR112020018533-7A patent/BR112020018533A2/pt unknown
- 2019-03-13 CA CA3093505A patent/CA3093505A1/en active Pending
- 2019-03-13 US US16/979,912 patent/US11554162B2/en active Active
- 2019-03-13 EA EA202092105A patent/EA202092105A1/ru unknown
- 2019-03-13 AU AU2019233637A patent/AU2019233637B2/en active Active
- 2019-03-13 EP EP19709078.0A patent/EP3764992B1/en active Active
- 2019-03-13 MX MX2020009470A patent/MX2020009470A/es unknown
- 2019-03-13 WO PCT/EP2019/056336 patent/WO2019175274A1/en unknown
- 2019-03-13 JP JP2020572617A patent/JP7372269B2/ja active Active
-
2020
- 2020-09-14 CL CL2020002369A patent/CL2020002369A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
IT201800003557A1 (it) | 2019-09-14 |
AU2019233637B2 (en) | 2024-08-15 |
BR112020018533A2 (pt) | 2020-12-29 |
US11554162B2 (en) | 2023-01-17 |
EP3764992A1 (en) | 2021-01-20 |
CA3093505A1 (en) | 2019-09-19 |
EP3764992B1 (en) | 2024-08-14 |
US20210361748A1 (en) | 2021-11-25 |
JP2021517591A (ja) | 2021-07-26 |
AU2019233637A1 (en) | 2020-10-22 |
MX2020009470A (es) | 2022-11-03 |
CL2020002369A1 (es) | 2021-05-07 |
JP7372269B2 (ja) | 2023-10-31 |
WO2019175274A1 (en) | 2019-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2659353T3 (es) | Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer | |
EA201991289A1 (ru) | Быстродействующие лекарственные соединения и пищевые добавки растительного происхождения | |
BR112015022306A2 (pt) | adoçante aperfeiçoado | |
PH12019500208A1 (en) | Spiro-lactam nmda receptor modulators and methods of using same | |
MX2021004999A (es) | Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos. | |
MX2013009007A (es) | Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. | |
AR104835A1 (es) | Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas | |
AR110060A1 (es) | Composiciones nutricionales que proporcionan el manejo dietético de cólicos | |
PH12018500036A1 (en) | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid | |
JP2014505702A5 (ru) | ||
PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
MX2020007760A (es) | Composiciones y metodos para mejorar la biodisponibilidad de 5-hidroxitriptofano. | |
AR043937A1 (es) | Composicion y metodo de inhibicion viral | |
EA202092105A1 (ru) | Фармацевтический состав или состав пищевой добавки на основе альфа-лактальбумина | |
CO2017006985A2 (es) | Producto de administración oral | |
BR112015012497A8 (pt) | combinações e composições farmacêuticas, seus usos, preparação combinada, e embalagem comercial | |
AR114427A1 (es) | Una composición de alimento para rumiantes que comprende polipéptidos que tienen actividad de muramidasa y métodos para mejorar la digestibilidad en rumiantes | |
MX2019004191A (es) | Composiciones de alimentos y bebidas que comprenden inhibidores de pde5. | |
WO2019040459A3 (en) | Composition and nutritional supplement made therefrom | |
ES2656666T3 (es) | Alimento para fines médicos especiales o formulación de suplemento alimenticio para tratar trastornos auditivos | |
RU2018131002A (ru) | Кормовая добавка для животных, содержащая ингибитор протеинкиназы с | |
Foran | Gastrointestinal symptoms: case report | |
BR112020019160A2 (pt) | Formulação | |
MX2017014725A (es) | Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas. | |
RU2008140019A (ru) | Способ лечения и профилактики эндометритов у коров |